Crinecerfont
HealthData.Gov
Updated Mar 24, 2026
About this dataset
Crenessity (crinecerfont) is an oral prescription capsule medication manufactured by Neurocrine Biosciences, Inc. It acts as a corticotropin-releasing factor type 1 receptor antagonist, available in 25mg, 50mg, and 100mg strengths. This information was generated using AI and is provided for informational and research purposes only.
Data and resources (1)
- HTML
Crinecerfont
Access the FDA dataset for Crinecerfont — ANDA 203308 submitted by Mylan Institutional LLC
Modified Dec 27, 2025